That's odd.

If in arbitration it was determined they'd have to come up with the full 6.5 million they could just sell shares then, right? They'd only "lose" their patents if they couldn't come up with the money at that point, I'd imagine.

So maybe this was the easiest way to get this done while the company continues to negotiate whatever it is that's happening behind the scenes?

What if the negotations are of the buyout variety and require the outstanding share count to remain static?

Or I suppse that could apply to the partnership if all the outstanding shares are about to be sold to Qilu, for instance, so they'd have their X% stake in Cytodyn.

Either of these flat out wild ass guesses would suppose that their business would be complete by the time any potential payment would come due. Then the new company pays or Cytodyn could pay with their up front monies.

I'd also imagine they wouldn't have done it this way without Sidley advising.

Just channeling my inner Goose. This is odd.